|
1
|
Mereu L, Pecorino B, Ferrara M, Tomaselli
V, Scibilia G and Scollo P: Neoadjuvant chemotherapy plus radical
surgery in locally advanced cervical cancer: Retrospective
single-center study. Cancers (Basel). 15(5207)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
de Foucher T, Bendifallah S, Ouldamer L,
Bricou A, Lavoue V, Varinot J, Canlorbe G, Carcopino X, Raimond E,
Monnier L, et al: Patterns of recurrence and prognosis in locally
advanced FIGO stage IB2 to IIB cervical cancer: Retrospective
multicentre study from the FRANCOGYN group. Eur J Surg Oncol.
45:659–665. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Qiu J, Sun S, Liu Q, Fu J, Huang Y and Hua
K: A comparison of concurrent chemoradiotherapy and radical surgery
in patients with specific locally advanced cervical cancer (stage
IB3, IIA2, IIICr): Trial protocol for a randomized controlled study
(C-CRAL trial). J Gynecol Oncol. 34(e64)2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gadducci A and Cosio S: Neoadjuvant
chemotherapy in locally advanced cervical cancer: Review of the
literature and perspectives of clinical research. Anticancer Res.
40:4819–4828. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Behtash N, Nazari Z, Ayatollahi H,
Modarres M, Ghaemmaghami F and Mousavi A: Neoadjuvant chemotherapy
and radical surgery compared to radical surgery alone in bulky
stage IB-IIA cervical cancer. Eur J Surg Oncol. 32:1226–1230.
2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Chen H, Liang C, Zhang L, Huang S and Wu
X: Clinical efficacy of modified preoperative neoadjuvant
chemotherapy in the treatment of locally advanced (stage IB2 to
IIB) cervical cancer: Randomized study. Gynecol Oncol. 110:308–315.
2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gong L, Zhang JW, Yin RT, Wang P, Liu H,
Zheng Y, Lou JY and Peng ZL: Safety and efficacy of neoadjuvant
chemotherapy followed by radical surgery versus radical surgery
alone in locally advanced cervical cancer patients. Int J Gynecol
Cancer. 26:722–728. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Katsumata N, Yoshikawa H, Kobayashi H,
Saito T, Kuzuya K, Nakanishi T, Yasugi T, Yaegashi N, Yokota H,
Kodama S, et al: Phase III randomised controlled trial of
neoadjuvant chemotherapy plus radical surgery vs radical surgery
alone for stages IB2, IIA2, and IIB cervical cancer: A Japan
clinical oncology group trial (JCOG 0102). Br J Cancer.
108:1957–1963. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhao H, He Y, Yang SL, Zhao Q and Wu YM:
Neoadjuvant chemotherapy with radical surgery vs radical surgery
alone for cervical cancer: A systematic review and meta-analysis.
Onco Targets Ther. 12:1881–1891. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cibula D, Raspollini MR, Planchamp F,
Centeno C, Chargari C, Felix A, Fischerová D, Jahnn-Kuch D, Joly F,
Kohler C, et al: ESGO/ESTRO/ESP guidelines for the management of
patients with cervical cancer-update 2023. Int J Gynecol Cancer.
33:649–666. 2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Vizza E, Corrado G, Zanagnolo V, Tomaselli
T, Cutillo G, Mancini E and Maggioni A: Neoadjuvant chemotherapy
followed by robotic radical hysterectomy in locally advanced
cervical cancer: A multi-institution study. Gynecol Oncol.
133:180–185. 2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang Y, Huang L, Wang D, Ren P, Hong Q
and Kang D: The ROBINS-I and the NOS had similar reliability but
differed in applicability: A random sampling observational studies
of systematic reviews/meta-analysis. J Evid Based Med. 14:112–122.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Namkoong SE, Park JS, Kim JW, Bae SN, Han
GT, Lee JM, Jung JK and Kim SJ: Comparative study of the patients
with locally advanced stages I and II cervical cancer treated by
radical surgery with and without preoperative adjuvant
chemotherapy. Gynecol Oncol. 59:136–142. 1995.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang Z, Chen D, Zhang J, Yao D, Gao K,
Wang H, Liu C, Yu J and Li L: The efficacy and safety of
neoadjuvant chemotherapy in the treatment of locally advanced
cervical cancer: A randomized multicenter study. Gynecol Oncol.
141:231–239. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kim HS, Kim JH, Chung HH, Kim HJ, Kim YB,
Kim JW, Park NH, Song YS and Kang SB: Significance of numbers of
metastatic and removed lymph nodes in FIGO stage IB1 to IIA
cervical cancer: Primary surgical treatment versus neoadjuvant
chemotherapy before surgery. Gynecol Oncol. 121:551–557.
2011.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ronsini C, Solazzo MC, Braca E, Andreoli
G, Vastarella MG, Cianci S, Capozzi VA, Torella M, Cobellis L and
De Franciscis P: Locally advanced cervical cancer: Neoadjuvant
treatment versus standard radio-chemotherapy-an updated
meta-analysis. Cancers (Basel). 16(2542)2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Coutinho F, Gokhale M, Doran C, Monberg M,
Yamada KS and Chen L: Treatment patterns and outcomes among locally
advanced cervical cancer patients receiving concurrent
chemoradiotherapy. J Clin Oncol. 41(e17511)2023.
|
|
19
|
Kenter GG, Greggi S, Vergote I, Katsaros
D, Kobierski J, van Doorn H, Landoni F, van der Velden J, Reed N,
Coens C, et al: Randomized phase III study comparing neoadjuvant
chemotherapy followed by surgery versus chemoradiation in stage
IB2-IIB cervical cancer: EORTC-55994. J Clin Oncol. 41:5035–5043.
2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Fu Y, Zhu T and Li H: Effectiveness of
cervical cancer therapy using neoadjuvant chemotherapy in
combination with radical surgery: A meta-analysis. Transl Cancer
Res. 6:228–237. 2017.
|
